NOMA vs GRNA
Comparison between Nomadar Corp - Class A (NOMA, Company) and GreenLight Biosciences Inc (GRNA, Company).
NOMA vs GRNA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
NOMA
$45M
Winner
GRNA
$45M
Max Drawdown
Winner
NOMA
86.33%
GRNA
98.70%
Sharpe Ratio
NOMA
-1.39
Winner
GRNA
-1.27
5Y Beta
NOMA
-0.18
GRNA
N/A
Industry
NOMA
Leisure
GRNA
N/A
P/E Ratio
NOMA
N/A
GRNA
-1.59
Debt to Equity
Winner
NOMA
0.00%
GRNA
112.33%
Free Cash Flow Yield
NOMA
-4.02%
GRNA
N/A
P/S Ratio
NOMA
46.55
Winner
GRNA
4.39
P/B Ratio
NOMA
4.85
Winner
GRNA
2.07
NOMA vs GRNA - Historical Returns
Returns include dividend reinvestment.
1M
NOMA
-5.12%
Winner
GRNA
+0.84%
3M
NOMA
-25.80%
Winner
GRNA
+42.28%
6M
Winner
NOMA
-27.92%
GRNA
-59.61%
1Y
NOMA
N/A
GRNA
-92.34%
Max(CAGR)
NOMA
-92.68%
Winner
GRNA
-89.56%
NOMA vs GRNA - Annual Returns (2022 - 2026)
Returns include dividend reinvestment.
| Year | NOMA | GRNA |
|---|---|---|
| 2026 | -28.25% | N/A |
| 2025 | -78.67% | N/A |
| 2023 | N/A | -73.96% |
| 2022 | N/A | -87.44% |
NOMA vs GRNA Drawdown Comparison
The maximum drawdown for NOMA was -86.33%, occurring on Jul 15, 2026. This drawdown has not yet recovered.
The maximum drawdown for GRNA was -98.70%, occurring on May 24, 2023. This drawdown has not yet recovered.
The current NOMA drawdown is -85.00%. The current GRNA drawdown is -97.79%.
| Rank | NOMA | GRNA |
|---|---|---|
| #1 | -86.33% Oct 31, 2025 - Jul 15, 2026 | -98.70% Mar 21, 2022 - May 24, 2023 |
| #2 | N/A | -47.65% Feb 3, 2022 - Mar 10, 2022 |
| #3 | N/A | -11.72% Mar 11, 2022 - Mar 15, 2022 |
| #4 | N/A | -0.30% Mar 15, 2022 - Mar 17, 2022 |
Correlation
Correlation between NOMA and GRNA is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: NOMA vs SPYGRNA vs SPY
More Comparisons
Compare with similar stocks